End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making

Dose-adjusted-EPOCH-R obviates the need for radiotherapy in most patients with primary mediastinal B-cell lymphoma. End-of-treatment PET, however, does not accurately identify patients at risk of treatment failure, thereby confounding clinical decision making. To define the role of PET in primary me...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Haematologica
Autors principals: Melani, Christopher, Advani, Ranjana, Roschewski, Mark, Walters, Kelsey M., Chen, Clara C., Baratto, Lucia, Ahlman, Mark A., Miljkovic, Milos D., Steinberg, Seth M., Lam, Jessica, Shovlin, Margaret, Dunleavy, Kieron, Pittaluga, Stefania, Jaffe, Elaine S., Wilson, Wyndham H.
Format: Artigo
Idioma:Inglês
Publicat: Ferrata Storti Foundation 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6068044/
https://ncbi.nlm.nih.gov/pubmed/29748435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2018.192492
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars